Answer
Reduced bilirubin glucuronidation may increase susceptibility to bone-marrow suppression, so the oncology team should know about Gilbert's syndrome or unexplained jaundice.
Sources for this answer
- ONIVYDE pegylated liposomal 4.3 mg/ml concentrate for dispersion for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.